HK59397A - Paroxetine hydrochloride anhydrate substantially free of bound organic solvent - Google Patents

Paroxetine hydrochloride anhydrate substantially free of bound organic solvent

Info

Publication number: HK59397A
Authority: HK; Hong Kong
Prior art keywords: organic solvent; substantially free; paroxetine hydrochloride; hydrochloride anhydrate; bound organic
Prior art date: 1995-02-06

Application number

HK59397A

Other languages

English (en)

Inventor

Victor Witold Jacewicz

Neal Ward

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-06

Filing date

1997-05-08

Publication date

1997-05-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK59397(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-02-06 Priority claimed from GBGB9502297.6A external-priority patent/GB9502297D0/en

1995-02-17 Priority claimed from GBGB9503112.6A external-priority patent/GB9503112D0/en

1995-05-15 Priority claimed from GBGB9509807.5A external-priority patent/GB9509807D0/en

1997-05-08 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

1997-05-16 Publication of HK59397A publication Critical patent/HK59397A/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Child & Adolescent Psychology (AREA)
Toxicology (AREA)
Hospice & Palliative Care (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

HK59397A 1995-02-06 1997-05-08 Paroxetine hydrochloride anhydrate substantially free of bound organic solvent HK59397A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9502297.6A GB9502297D0 (en)	1995-02-06	1995-02-06	Novel compound
GBGB9503112.6A GB9503112D0 (en)	1995-02-17	1995-02-17	Novel compound
GBGB9509807.5A GB9509807D0 (en)	1995-05-15	1995-05-15	Novel compounds

Publications (1)

Publication Number	Publication Date
HK59397A true HK59397A (en)	1997-05-16

Family

ID=27267578

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK59397A HK59397A (en)	1995-02-06	1997-05-08	Paroxetine hydrochloride anhydrate substantially free of bound organic solvent

Country Status (47)

Country	Link
EP (3)	EP0808314B1 (xx)
JP (2)	JP2915338B2 (xx)
KR (1)	KR100289885B1 (xx)
CN (3)	CN1289496C (xx)
AR (2)	AR001982A1 (xx)
AT (1)	AT407528B (xx)
AU (2)	AU701518C (xx)
BE (1)	BE1009112A3 (xx)
BG (1)	BG62967B1 (xx)
BR (1)	BR9600534A (xx)
CA (4)	CA2210023C (xx)
CH (3)	CH688353A5 (xx)
CZ (1)	CZ297171B6 (xx)
DE (3)	DE69631298T2 (xx)
DK (2)	DK11996A (xx)
DZ (1)	DZ1989A1 (xx)
ES (1)	ES2114471B1 (xx)
FI (3)	FI111544B (xx)
FR (1)	FR2730232B1 (xx)
GR (1)	GR1002466B (xx)
HK (1)	HK59397A (xx)
HU (1)	HUP9600255A1 (xx)
IE (1)	IE80500B1 (xx)
IL (1)	IL117035A (xx)
IT (1)	IT1289532B1 (xx)
LU (1)	LU88711A1 (xx)
LV (1)	LV11618B (xx)
MA (1)	MA23802A1 (xx)
MC (1)	MC2411A1 (xx)
MX (1)	MX9600484A (xx)
MY (1)	MY132529A (xx)
NL (1)	NL1002248C2 (xx)
NO (3)	NO301009B1 (xx)
NZ (1)	NZ280943A (xx)
OA (1)	OA10261A (xx)
PL (1)	PL189247B1 (xx)
PT (1)	PT101827B (xx)
RO (1)	RO112426B1 (xx)
RU (1)	RU2125052C1 (xx)
SE (1)	SE521084C2 (xx)
SG (1)	SG43787A1 (xx)
SI (2)	SI21923B (xx)
SK (1)	SK283608B6 (xx)
TR (1)	TR199600096A2 (xx)
TW (1)	TW503238B (xx)
UA (1)	UA49796C2 (xx)
WO (1)	WO1996024595A1 (xx)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3882224B2 (ja)	1996-05-31	2007-02-14	旭硝子株式会社	パロキセチンの製造方法
DE69739561D1 (de)	1996-06-13	2009-10-15	Sumitomo Chemical Co	Piperidin Derivative als Zwischenprodukte zur Herstellung von Paroxetine und Verfahren zu ihrer Herstellung
WO1998002556A2 (en) *	1996-07-15	1998-01-22	Smithkline Beecham Plc	Screening for and use of an esterase for a stereospecific resolution
US5672612A (en) *	1996-09-09	1997-09-30	Pentech Pharmaceuticals, Inc.	Amorphous paroxetine composition
US6638948B1 (en)	1996-09-09	2003-10-28	Pentech Pharmaceuticals, Inc.	Amorphous paroxetine composition
CA2193939C (en) *	1996-12-24	2002-02-12	K.S. Keshava Murthy	Useful form of anhydrous paroxetine hydrochloride
KR100543614B1 (ko) *	1997-06-10	2006-01-20	신톤 비.브이.	4-페닐피페리딘 화합물
ES2150808T3 (es) *	1997-08-08	2000-12-01	Aventis Pharma Gmbh	Forma cristalina de (4-trifluorometil)-anilida de acido 5-metilisoxazol-4-carboxilico.
GB9726907D0 (en) *	1997-12-19	1998-02-18	Smithkline Beecham Plc	Novel compounds
CA2323896A1 (en) *	1998-03-16	1999-09-23	Andrew Simon Craig	Crystalline form of paroxetine
GB9806312D0 (en) *	1998-03-24	1998-05-20	Smithkline Beecham Plc	Novel formulations
US6699882B2 (en)	1998-03-24	2004-03-02	Smithkline Beecham P.L.C.	Paroxetine compositions
AU2003200534B2 (en) *	1998-03-24	2004-12-02	Smithkline Beecham Plc	Paroxetine compositions
JP3796351B2 (ja) *	1998-04-13	2006-07-12	住友化学株式会社	パロキセチン塩酸塩無水和物の乾燥方法
GB9812941D0 (en) *	1998-06-16	1998-08-12	Smithkline Beecham Plc	Method of treatment
CH689805A8 (fr) *	1998-07-02	2000-02-29	Smithkline Beecham Plc	Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2138937B1 (es)	1998-07-07	2000-10-01	Medichem Sa	Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
PT1100796E (pt) *	1998-08-07	2003-09-30	Smithkline Beecham Plc	Processo para a preparacao de um cloridrato de paroxetina na forma anidra nao cristalina
GB9824298D0 (en) *	1998-11-05	1998-12-30	Smithkline Beecham Plc	Novel process
GB9826175D0 (en) *	1998-11-28	1999-01-20	Smithkline Beecham Plc	Novel process
GB9826176D0 (en) *	1998-11-28	1999-01-20	Smithkline Beecham Plc	Novel process
GB9826242D0 (en) *	1998-11-30	1999-01-20	Smithkline Beecham Plc	Novel process
ES2211232T3 (es) *	1998-11-30	2004-07-01	Smithkline Beecham Plc	Solvatos mixtos de paroxetina-propan-2-ol.
GB9826178D0 (en) *	1998-11-30	1999-01-20	Smithkline Beecham Plc	Novel process
GB9826180D0 (en) *	1998-11-30	1999-01-20	Smithkline Beecham Plc	Novel process
GB9826171D0 (en) *	1998-11-30	1999-01-20	Smithkline Beecham Plc	Novel compounds
GB9828767D0 (en) *	1998-12-29	1999-02-17	Smithkline Beecham Plc	Novel process
WO2000054775A1 (de) *	1999-03-12	2000-09-21	Basf Ag	Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
GB9914585D0 (en) *	1999-06-22	1999-08-25	Smithkline Beecham Plc	Novel process
GB9914583D0 (en) *	1999-06-22	1999-08-25	Smithkline Beecham Plc	Novel process
GB9919001D0 (en) *	1999-08-12	1999-10-13	Smithkline Beecham Plc	Novel process
GB9923446D0 (en) *	1999-10-04	1999-12-08	Smithkline Beecham Plc	Novel process
GB9923439D0 (en) *	1999-10-04	1999-12-08	Smithkline Beecham Plc	Novel process
GB9923445D0 (en) *	1999-10-04	1999-12-08	Smithkline Beecham Plc	Novel process
HU226912B1 (en) *	2000-04-07	2010-03-01	Richter Gedeon Nyrt	New paroxetin salt and medicament containing it
JPWO2002022609A1 (ja) *	2000-09-14	2004-01-22	旭硝子株式会社	実質的に有機溶媒を含まないパロキセチン塩類の製造方法
AU2002259114A1 (en) *	2002-02-22	2003-09-09	Teva Pharmaceutical Industries Ltd.	Preparation of paroxetine involving novel intermediates
WO2007062147A1 (en) *	2005-11-22	2007-05-31	Teva Pharmaceutical Industries Ltd.	Crystal forms of cinacalcet hci and processes for their preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1422263A (en) *	1973-01-30	1976-01-21	Ferrosan As	4-phenyl-piperidine compounds
GB8430581D0 (en) *	1984-12-04	1985-01-09	Ferrosan As	Treatment
DE3688827T2 (de) *	1985-10-25	1994-03-31	Beecham Group Plc	Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
GB8626936D0 (en) *	1986-11-11	1986-12-10	Ferrosan As	Treatment
DK715988D0 (da) *	1988-12-22	1988-12-22	Ferrosan As	Etherifikation og dealkylering af piperidin-derivater samt intermediater
DK716088D0 (da) *	1988-12-22	1988-12-22	Ferrosan As	Reduktion af piperidin-dion-derivater samt intermediat
KR930702000A (ko) *	1990-11-24	1993-09-08	데이빗 로버츠	노년기 치매, 식용항진, 편두통, 또는 식용불량의 치료를 위한 파로세틴의 사용
GB9325644D0 (en) *	1993-12-15	1994-02-16	Smithkline Beecham Plc	Novel formulation

1996
- 1996-02-01 SK SK143-96A patent/SK283608B6/sk not_active IP Right Cessation
- 1996-02-01 AR ARP960101230A patent/AR001982A1/es not_active Application Discontinuation
- 1996-02-02 EP EP96903970A patent/EP0808314B1/en not_active Expired - Lifetime
- 1996-02-02 MY MYPI96000383A patent/MY132529A/en unknown
- 1996-02-02 AU AU43328/96A patent/AU701518C/en not_active Ceased
- 1996-02-02 CZ CZ0032096A patent/CZ297171B6/cs not_active IP Right Cessation
- 1996-02-02 DE DE1996631298 patent/DE69631298T2/de not_active Expired - Lifetime
- 1996-02-02 DE DE19603797A patent/DE19603797C2/de not_active Revoked
- 1996-02-02 FR FR9601297A patent/FR2730232B1/fr not_active Expired - Fee Related
- 1996-02-02 RO RO96-00183A patent/RO112426B1/ro unknown
- 1996-02-02 DE DE69621777T patent/DE69621777T2/de not_active Expired - Lifetime
- 1996-02-02 WO PCT/EP1996/000447 patent/WO1996024595A1/en active IP Right Grant
- 1996-02-02 EP EP01115079A patent/EP1136490B1/en not_active Expired - Lifetime
- 1996-02-02 BR BR9600534A patent/BR9600534A/pt not_active IP Right Cessation
- 1996-02-02 EP EP03078024A patent/EP1378508A1/en not_active Withdrawn
- 1996-02-02 MC MC2329A patent/MC2411A1/xx unknown
- 1996-02-02 AU AU47864/96A patent/AU4786496A/en not_active Abandoned
- 1996-02-02 IE IE960104A patent/IE80500B1/en not_active IP Right Cessation
- 1996-02-02 LV LVP-96-31A patent/LV11618B/en unknown
- 1996-02-02 MX MX9600484A patent/MX9600484A/es not_active IP Right Cessation
- 1996-02-03 KR KR1019960002620A patent/KR100289885B1/ko not_active IP Right Cessation
- 1996-02-03 SG SG1996000861A patent/SG43787A1/en unknown
- 1996-02-04 DZ DZ960030A patent/DZ1989A1/fr active
- 1996-02-05 IT IT96MI000203A patent/IT1289532B1/it active IP Right Grant
- 1996-02-05 CA CA002210023A patent/CA2210023C/en not_active Expired - Fee Related
- 1996-02-05 NO NO960472A patent/NO301009B1/no not_active IP Right Cessation
- 1996-02-05 JP JP8018679A patent/JP2915338B2/ja not_active Expired - Fee Related
- 1996-02-05 BE BE9600101A patent/BE1009112A3/fr not_active IP Right Cessation
- 1996-02-05 LU LU88711A patent/LU88711A1/fr unknown
- 1996-02-05 CA CA002211522A patent/CA2211522C/en not_active Expired - Fee Related
- 1996-02-05 AT AT0021096A patent/AT407528B/de not_active IP Right Cessation
- 1996-02-05 UA UA96020442A patent/UA49796C2/uk unknown
- 1996-02-05 CA CA002210022A patent/CA2210022C/en not_active Expired - Fee Related
- 1996-02-05 HU HU9600255A patent/HUP9600255A1/hu unknown
- 1996-02-05 ES ES09600262A patent/ES2114471B1/es not_active Expired - Fee Related
- 1996-02-05 NZ NZ280943A patent/NZ280943A/en not_active IP Right Cessation
- 1996-02-05 GR GR960100038A patent/GR1002466B/el not_active IP Right Cessation
- 1996-02-05 FI FI960519A patent/FI111544B/fi not_active IP Right Cessation
- 1996-02-05 PL PL96312646A patent/PL189247B1/pl unknown
- 1996-02-05 CA CA002168829A patent/CA2168829C/en not_active Expired - Fee Related
- 1996-02-05 RU RU96102180A patent/RU2125052C1/ru not_active IP Right Cessation
- 1996-02-05 IL IL11703596A patent/IL117035A/xx unknown
- 1996-02-05 BG BG100333A patent/BG62967B1/bg unknown
- 1996-02-05 CN CNB2004100855519A patent/CN1289496C/zh not_active Expired - Fee Related
- 1996-02-05 SI SI9600378A patent/SI21923B/sl not_active IP Right Cessation
- 1996-02-05 NL NL1002248A patent/NL1002248C2/xx not_active IP Right Cessation
- 1996-02-05 TW TW085101374A patent/TW503238B/zh not_active IP Right Cessation
- 1996-02-05 MA MA24157A patent/MA23802A1/fr unknown
- 1996-02-05 CN CN96103526A patent/CN1090187C/zh not_active Expired - Fee Related
- 1996-02-05 DK DK011996A patent/DK11996A/da not_active Application Discontinuation
- 1996-02-05 SE SE9600406A patent/SE521084C2/sv not_active IP Right Cessation
- 1996-02-05 SI SI9600036A patent/SI9600036B/sl not_active IP Right Cessation
- 1996-02-06 CH CH00304/96A patent/CH688353A5/de not_active IP Right Cessation
- 1996-02-06 CH CH02051/98A patent/CH689804A5/de not_active IP Right Cessation
- 1996-02-06 OA OA60773A patent/OA10261A/en unknown
- 1996-02-06 PT PT101827A patent/PT101827B/pt not_active IP Right Cessation
- 1996-02-06 TR TR96/00096A patent/TR199600096A2/xx unknown
- 1996-02-06 CH CH01510/97A patent/CH689229A5/de not_active IP Right Cessation
1997
- 1997-02-28 NO NO19970939A patent/NO311519B1/no not_active IP Right Cessation
- 1997-05-08 HK HK59397A patent/HK59397A/xx not_active IP Right Cessation
1998
- 1998-12-02 JP JP10342812A patent/JPH11228571A/ja active Pending
2000
- 2000-08-31 CN CN001268872A patent/CN1216055C/zh not_active Expired - Fee Related
2001
- 2001-02-12 DK DKPA200100223 patent/DK200100223A/da not_active Application Discontinuation
- 2001-10-18 NO NO20015070A patent/NO20015070D0/no not_active Application Discontinuation
2002
- 2002-10-18 AR ARP020103931A patent/AR036856A2/es unknown
2003
- 2003-02-03 FI FI20030162A patent/FI20030162A/fi unknown
- 2003-03-12 FI FI20030370A patent/FI20030370A/fi not_active Application Discontinuation

Also Published As

Publication number	Publication date
ES2114471B1 (es)	1999-08-16
CA2210022A1 (en)	1996-08-07
NO20015070D0 (no)	2001-10-18
TW503238B (en)	2002-09-21
JPH11228571A (ja)	1999-08-24
MX9600484A (es)	1997-01-31
DE69621777D1 (de)	2002-07-18
MA23802A1 (fr)	1996-10-01
NO960472D0 (no)	1996-02-05
HUP9600255A1 (en)	1997-03-28
DE19603797A1 (de)	1996-08-14
FI111544B (fi)	2003-08-15
NO20015070L (no)	1996-08-07
DK200100223A (xx)	2001-02-12
FR2730232A1 (fr)	1996-08-09
FI960519A (fi)	1996-08-07
CA2210023C (en)	1999-02-09
GR1002466B (el)	1996-11-06
DE69631298D1 (de)	2004-02-12
LV11618A (lv)	1996-12-20
SI9600036B (sl)	2006-12-31
NO311519B1 (no)	2001-12-03
CZ32096A3 (en)	1996-08-14
AR036856A2 (es)	2004-10-06
NL1002248A1 (nl)	1996-08-06
EP1378508A1 (en)	2004-01-07
ITMI960203A1 (it)	1997-08-05
PT101827B (pt)	1997-08-29
MC2411A1 (fr)	1996-12-02
MY132529A (en)	2007-10-31
KR960031409A (ko)	1996-09-17
CA2168829C (en)	1997-12-16
RU2125052C1 (ru)	1999-01-20
ES2114471A1 (es)	1998-05-16
AR001982A1 (es)	1998-01-07
IL117035A (en)	2000-02-29
CN1636993A (zh)	2005-07-13
DK11996A (da)	1996-08-07
DZ1989A1 (fr)	2002-10-15
CN1143643A (zh)	1997-02-26
FI960519A0 (fi)	1996-02-05
IT1289532B1 (it)	1998-10-15
HU9600255D0 (en)	1996-03-28
SG43787A1 (en)	1997-11-14
CN1090187C (zh)	2002-09-04
NO301009B1 (no)	1997-09-01
FI20030370A (fi)	2003-03-12
CH689229A5 (de)	1998-12-31
FI20030162A (fi)	2003-02-03
EP1136490B1 (en)	2004-01-07
CH688353A5 (de)	1997-08-15
DE69631298T2 (de)	2004-11-18
DE19603797C2 (de)	1998-11-12
NO970939L (no)	1996-08-07
AU701518B2 (en)	1999-01-28
RO112426B1 (ro)	1997-09-30
NO301009B3 (xx)	2003-01-06
SI21923A (sl)	2006-06-30
CN1310180A (zh)	2001-08-29
DE69621777T2 (de)	2003-01-02
SE9600406L (sv)	1996-08-07
MX198371B (xx)	2000-08-29
ATA21096A (de)	2000-08-15
BE1009112A3 (fr)	1996-11-05
IL117035A0 (en)	1996-09-12
NZ280943A (en)	1997-01-29
LV11618B (en)	1997-04-20
IE80500B1 (en)	1998-08-12
SK14396A3 (en)	1996-11-06
EP1136490A1 (en)	2001-09-26
PL312646A1 (en)	1996-08-19
CA2210022C (en)	2005-09-13
CN1216055C (zh)	2005-08-24
BR9600534A (pt)	1997-05-13
FR2730232B1 (fr)	1997-08-01
CA2211522C (en)	1999-12-07
NO960472L (no)	1996-08-07
WO1996024595A1 (en)	1996-08-15
PT101827A (pt)	1996-09-30
AU4332896A (en)	1996-08-15
NO970939D0 (no)	1997-02-28
PL189247B1 (pl)	2005-07-29
IE960104A1 (en)	1996-08-07
JP2915338B2 (ja)	1999-07-05
SE521084C2 (sv)	2003-09-30
UA49796C2 (uk)	2002-10-15
BG100333A (bg)	1996-08-30
CA2210023A1 (en)	1996-08-07
CZ297171B6 (cs)	2006-09-13
BG62967B1 (bg)	2000-12-29
OA10261A (en)	1997-09-19
TR199600096A2 (tr)	1996-08-21
CA2168829A1 (en)	1996-08-07
JPH08245620A (ja)	1996-09-24
EP0808314B1 (en)	2002-06-12
ITMI960203A0 (xx)	1996-02-05
EP0808314A1 (en)	1997-11-26
AT407528B (de)	2001-04-25
SE9600406D0 (sv)	1996-02-05
NL1002248C2 (nl)	1996-09-11
SI21923B (sl)	2006-12-31
SI9600036A (en)	1996-10-31
SK283608B6 (sk)	2003-10-07
AU4786496A (en)	1996-08-27
CH689804A5 (de)	1999-11-30
AU701518C (en)	2006-12-07
LU88711A1 (fr)	1996-08-23
CN1289496C (zh)	2006-12-13
CA2211522A1 (en)	1996-08-07
KR100289885B1 (ko)	2001-05-15

Legal Events

Date	Code	Title	Description
2004-12-15	PF	Patent in force
2013-08-23	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20130131

Publication	Publication Date	Title
HK59397A (en)	1997-05-16	Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
DE69631390D1 (de)	2004-02-26	Substituierte Benzylaminpiperidin-Verbindungen
NO991563D0 (no)	1999-03-30	N-substituerte azaheterosykliske forbindelser
GB9518113D0 (en)	1995-11-08	Polymorphic form of a tachykinin receptor antagonist
PL322722A1 (en)	1998-02-16	Novel heterocyclic compounds
PL342692A1 (en)	2001-07-02	Derivatives of 2-arylethyl-(piperidin-4-ylmethyl)amine as antagonists of muscarinic receptor
GB2297550C2 (en)	1997-04-09	Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
NO991564L (no)	1999-06-04	N-substituerte azaheterosykliske forbindelser
NO994049D0 (no)	1999-08-23	Metode for å fremstille farmasöytiske forbindelser
PL325637A1 (en)	1998-08-03	Novel heterocyclic compounds
IL136590A0 (en)	2001-06-14	Process for preparation of paroxetine hydrochloride
AU740561C (en)	2005-12-08	Paroxetine hydrochloride anhydrate
LT96007A (en)	1996-10-25	Paroxetine hydrochloride anhydrate and process for preparing thereof
UY24621A1 (es)	2001-08-27	Nuevos compuestos
IL127114A0 (en)	1999-09-22	Substituted heterocyclic compounds
GB9501038D0 (en)	1995-03-08	Organic compounds
GB9501155D0 (en)	1995-03-08	Organic compounds
GB9500086D0 (en)	1995-03-01	Organic compounds
GB9500924D0 (en)	1995-03-08	Organic compounds
GB9501035D0 (en)	1995-03-08	Organic compounds
GB9501036D0 (en)	1995-03-08	Organic compounds
GB9504073D0 (en)	1995-04-19	Organic compounds
GB9503553D0 (en)	1995-04-12	Organic compounds
GB9505080D0 (en)	1995-05-03	Organic compounds
GB9502771D0 (en)	1995-03-29	Organic compounds